{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:44:41Z","timestamp":1771659881391,"version":"3.50.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>A great number of anti-inflammatory drugs have been suggested in the treatment of SARS-CoV-2 infection. Reparixin, a non-competitive allosteric inhibitor of the CXCL8 (IL-8) receptors C-X-C chemokine receptor type 1 (CXCR1) and C-X-C chemokine receptor type 2 (CXCR2), has already been tried out as a treatment in different critical settings. Due to the contrasting existing literature, we decided to perform the present meta-analysis of randomized controlled trials (RCTs) to investigate the effect of the use of reparixin on survival in patients at high risk for in-hospital mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We created a search strategy to include any human RCTs performed with reparixin utilization in patients at high risk\u00a0for in-hospital mortality, excluding oncological patients. Two trained, independent authors searched PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) for appropriate studies. Furthermore, references of review articles and included RCTs were screened to identify more studies. No language restrictions were enforced. To assess the risk of bias of included trials, the Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) was used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, six studies were included and involved 406 patients (220 received reparixin and 186 received the comparator). The all-cause mortality in the reparixin group was significantly lower than that in the control group [5\/220 (2.3%) in the reparixin group vs. 12\/186 (6.5%) in the control group, odds ratio = 0.33 (95% confidence interval 0.12 to 0.96), <jats:italic>p<\/jats:italic>-value for effect 0.04, <jats:italic>p<\/jats:italic> for heterogeneity 0.20, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 36%]. In addition, no difference in the rate of pneumonia, sepsis, or non-serious infections was shown between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our meta-analysis of randomized trials suggests that short-term inhibition of CXCL8 activity improved survival in patients at high risk for in-hospital mortality without increasing the risk of infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Meta-analysis registration<\/jats:title><jats:p>PROSPERO, identifier CRD42021254467.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.932251","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T07:41:40Z","timestamp":1658734900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The effect of reparixin on survival in patients at high risk\u00a0for in-hospital mortality: a meta-analysis of randomized trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Giovanni","family":"Landoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Zangrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioia","family":"Piersanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Scquizzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.588654","article-title":"Challenges for drug repurposing in the COVID-19 pandemic era","volume":"11","author":"Sultana","year":"2020","journal-title":"Front Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/08923973.2021.1931302","article-title":"Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications","volume":"43","author":"Shawki","year":"2021","journal-title":"Immunopharmacol immunotoxicol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16001","article-title":"COVID-19 and islet transplantation: Different twins","volume":"20","author":"Piemonti","year":"2020","journal-title":"Am J Transpl"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1702590","DOI":"10.1183\/13993003.02590-2017","article-title":"Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS","volume":"52","author":"Gr\u00e9goire","year":"2018","journal-title":"Eur Respir J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00641","article-title":"Neutrophils, crucial, or harmful immune cells involved in coronavirus infection: A bioinformatics study","volume":"11","author":"Hemmat","year":"2020","journal-title":"Front Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150862","article-title":"Self-sustaining interleukin-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19","volume":"6","author":"Kaiser","year":"2021","journal-title":"JCI Insight"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050656","article-title":"Neutrophils and contact activation of coagulation as potential drivers of COVID-19","volume":"142","author":"Busch","year":"2020","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003568","article-title":"A neutrophil activation signature predicts critical illness and mortality in COVID-19","volume":"5","author":"Meizlish","year":"2021","journal-title":"Blood Advances"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02374-0","article-title":"Neutrophil-To-Lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage","volume":"18","author":"Liu","year":"2020","journal-title":"J Trans Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2\u2013triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerging Microbes Infect"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab437","article-title":"Increased peripheral blood neutrophil activation phenotypes and NETosis in critically ill COVID-19 patients: A case series and review of the literature","volume":"74","author":"Masso-Silva","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023656","article-title":"The prognostic value of IL-8 for the death of severe or critical patients with COVID-19","volume":"100","author":"Li","year":"2021","journal-title":"Medicine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13354","article-title":"A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of d-dimer, c-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity","volume":"43","author":"Singh","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40121-022-00644-6","article-title":"A multicenter phase 2 randomized controlled study on the efficacy and safety of reparixin in the treatment of hospitalized patients with COVID-19 pneumonia","volume":"26","author":"Landoni","year":"2022","journal-title":"Infect Dis Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2290-8","article-title":"Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia","volume":"22","author":"Mikacenic","year":"2018","journal-title":"Crit Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): A review of the pathophysiology","volume":"20","author":"Millar","year":"2016","journal-title":"Crit Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/SHK.0000000000001467","article-title":"Toll-like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients","volume":"54","author":"Lenz","year":"2020","journal-title":"Shock."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78476-y","article-title":"Prognostic value of Neutrophil\/Lymphocyte ratio and mean platelet Volume\/Platelet ratio for 1-year mortality in critically ill patients","volume":"10","author":"Ham","year":"2020","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8839506","article-title":"Red blood cell distribution width, neutrophil-To-Lymphocyte ratio, and in-hospital mortality in dyspneic patients admitted to the emergency department","volume":"2020","author":"Yan","year":"2020","journal-title":"Dis Markers"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.20.14310-4","article-title":"High neutrophil-to-Lymphocyte ratio is associated with poor clinical outcome in patients with critically ill stroke","volume":"86","author":"Hu","year":"2020","journal-title":"Minerva Anestesiologica"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.09.014","article-title":"Neutrophil-lymphocyte ratio is associated with all-cause mortality among critically ill patients with acute kidney injury","volume":"490","author":"Fan","year":"2019","journal-title":"Clinica Chimica Acta"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001136","article-title":"The association between the neutrophil-To-Lymphocyte ratio and mortality in patients with acute respiratory distress syndrome: A retrospective cohort study","volume":"51","author":"Li","year":"2019","journal-title":"Shock"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000000980","article-title":"The prognostic value of neutrophil-to-Lymphocyte ratio on mortality in critically ill trauma patients","volume":"81","author":"Dilektasli","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201811-2111OC","article-title":"A novel assay for neutrophil extracellular trap formation independently predicts disseminated intravascular coagulation and mortality in critically ill patients","volume":"200","author":"Abrams","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000221","article-title":"Neutrophil extracellular traps in sepsis","volume":"42","author":"Camicia","year":"2014","journal-title":"Shock"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000719","article-title":"Evidence of netosis in septic shock-induced disseminated intravascular coagulation","volume":"47","author":"Delabranche","year":"2017","journal-title":"Shock: Injury Inflamm Sepsis: Lab Clin Approaches"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98178","article-title":"Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury","volume":"3","author":"Lefran\u00e7ais","year":"2018","journal-title":"JCI Insight"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-017-0651-5","article-title":"Extracellular histones are clinically relevant mediators in the pathogenesis of acute respiratory distress syndrome","volume":"18","author":"Lv","year":"2017","journal-title":"Respir Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2684-2","article-title":"Plasma Stnfr1 and IL8 for prognostic enrichment in sepsis trials: A prospective cohort study","volume":"23","author":"Anderson","year":"2019","journal-title":"Crit Care"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/146.2.427","article-title":"Elevated levels of NAP-1\/Interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality","volume":"146","author":"Miller","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7458451","article-title":"The neutrophil percentage-To-Albumin ratio as a new predictor of all-cause mortality in patients with cardiogenic shock","volume":"2020","author":"Yu","year":"2020","journal-title":"BioMed Res Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8137576","article-title":"Association between neutrophil percentage-To-Albumin ratio and all-cause mortality in critically ill patients with coronary artery disease","volume":"2020","author":"Sun","year":"2020","journal-title":"BioMed Res Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039860","article-title":"Association between neutrophil-to-Albumin ratio and mortality in patients with cardiogenic shock: A retrospective cohort study","volume":"10","author":"Peng","year":"2020","journal-title":"BMJ Open"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820000771","article-title":"Increased neutrophil percentage-to-Albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock","volume":"148","author":"Gong","year":"2020","journal-title":"Epidemiol Infect"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2748","article-title":"Phase ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2-Negative metastatic breast cancer","volume":"23","author":"Schott","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63089","article-title":"CXCR1\/2 inhibition enhances pancreatic islet survival after transplantation","volume":"122","author":"Citro","year":"2012","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1480","article-title":"Targeting CXCR1\/2 does not improve insulin secretion after pancreatic islet transplantation: A phase 3, double-blind, randomized, placebo-controlled trial in type 1 diabetes","volume":"43","author":"Maffi","year":"2020","journal-title":"Diabetes Care"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1243-8","article-title":"A window-of-Opportunity trial of the CXCR1\/2 inhibitor reparixin in operable HER-2-Negative breast cancer","volume":"22","author":"Goldstein","year":"2020","journal-title":"Breast Cancer Res"},{"key":"B48","unstructured":"A double-blind study of paclitaxel in combination with reparixin or placebo for metastatic triple-negative breast cancer (FRIDA)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/039463200702000104","article-title":"Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia","volume":"20","author":"Leitner","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1177\/09636897211001774","article-title":"Post-hoc analysis of a randomized, double blind, prospective study at the university of Chicago: Additional standardizations of trial protocol are needed to evaluate the effect of a CXCR1\/2 inhibitor in islet allotransplantation","volume":"30","author":"Bachul","year":"2021","journal-title":"Cell Transpl"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.11.417","article-title":"405: A multicenter prospective, randomized, placebo-controlled trial of a CXCL8 inhibitor (Reparixin) to prevent primary graft dysfunction after lung transplantation","volume":"27","author":"Meyers","year":"2008","journal-title":"J Heart Lung Transpl"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12488","article-title":"A pilot study on reparixin, a CXCR1\/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery","volume":"180","author":"Opfermann","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B53","unstructured":"Pilot study of reparixin for early allograft dysfunction prevention in liver transplantation"},{"key":"B54","unstructured":"Reparixin in prevention of delayed graft function after kidney transplantation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16695","article-title":"Targeting CXCR1\/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients","volume":"21","author":"Witkowski","year":"2021","journal-title":"Am J Transplant"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.06.060","article-title":"\u201cChemokine receptors as therapeutic targets: Why aren\u2019t there more drugs?\u201d","volume":"746","author":"Solari","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/17425255.2020.1711884","article-title":"Clinical significance of chemokine receptor antagonists","volume":"16","author":"Miao","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/aas.13451","article-title":"Neutrophil activation in septic acute kidney injury: A Post hoc analysis of the FINNAKI study","volume":"63","author":"T\u00f6rnblom","year":"2019","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2342-8","article-title":"A prospective investigation of interleukin-8 levels in pediatric acute respiratory failure and acute respiratory distress syndrome","volume":"23","author":"Flori","year":"2019","journal-title":"Crit Care"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001584","article-title":"Microvesicle tissue factor activity and interleukin-8 levels are associated with mortality in patients with influenza A\/H1N1 infection","volume":"44","author":"Rondina","year":"2016","journal-title":"Crit Care Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09911014","article-title":"Biological markers for recovery of kidney study I: Biomarker enhanced risk prediction for adverse outcomes in critically ill patients receiving RRT","volume":"10","author":"Pike","year":"2015","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B62","unstructured":"Reparixin as add-on therapy to standard of care to limit disease progression in adult patients with COVID-19"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.808797","article-title":"The role of interleukin-8 in lung inflammation and injury: Implications for the management of COVID-19 and hyperinflammatory acute respiratory distress syndrome","volume":"12","author":"Cesta","year":"2022","journal-title":"Front Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141813","article-title":"Phospholipase D2 drives mortality in sepsis by inhibiting neutrophil extracellular trap formation and down-regulating CXCR2","volume":"212","author":"Lee","year":"2015","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01023","article-title":"Wip1 deficiency promotes neutrophil recruitment to the infection site and improves sepsis outcome","volume":"8","author":"Shen","year":"2017","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0811402","article-title":"Lipid-Cytokine-Chemokine cascades orchestrate leukocyte recruitment in inflammation","volume":"91","author":"Sadik","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.49","article-title":"Neutrophil migration in infection and wound repair: Going forward in reverse","volume":"16","author":"De Oliveira","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.152371","article-title":"The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates","volume":"102","author":"Uddin","year":"2017","journal-title":"Haematologica"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747198","article-title":"CXCR2 is critical for bacterial control and development of joint damage and pain in staphylococcus aureus-induced septic arthritis in mouse","volume":"48","author":"Boff","year":"2018","journal-title":"Eur J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.932251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T07:41:46Z","timestamp":1658734906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.932251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2022.932251"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.932251","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"article-number":"932251"}}